OBJECTIVE: To identify prediction factors for the development of leptospirosis-associated pulmonary hemorrhage syndrome (LPHS). METHODS: We conducted a prospective cohort study. The study comprised of 203 patients, aged > or =14 years, admitted with complications of the severe form of leptospirosis at the Emílio Ribas Institute of Infectology (Sao Paulo, Brazil) between 1998 and 2004. Laboratory and demographic data were obtained and the severity of illness score and involvement of the lungs and others organs were determined. Logistic regression was performed to identify independent predictors of LPHS. A prospective validation cohort of 97 subjects with severe form of leptospirosis admitted at the same hospital between 2004 and 2006 was used to independently evaluate the predictive value of the model. RESULTS: The overall mortality rate was 7.9%. Multivariate logistic regression revealed that five factors were independently associated with the development of LPHS: serum potassium (mmol/L) (OR = 2.6; 95% CI = 1.1-5.9); serum creatinine (micromol/L) (OR = 1.2; 95% CI = 1.1-1.4); respiratory rate (breaths/min) (OR = 1.1; 95% CI = 1.1-1.2); presenting shock (OR = 69.9; 95% CI = 20.1-236.4), and Glasgow Coma Scale Score (GCS) < 15 (OR = 7.7; 95% CI = 1.3-23.0). We used these findings to calculate the risk of LPHS by the use of a spreadsheet. In the validation cohort, the equation classified correctly 92% of patients (Kappa statistic = 0.80). CONCLUSIONS: We developed and validated a multivariate model for predicting LPHS. This tool should prove useful in identifying LPHS patients, allowing earlier management and thereby reducing mortality. 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
OBJECTIVE: To identify prediction factors for the development of leptospirosis-associatedpulmonary hemorrhage syndrome (LPHS). METHODS: We conducted a prospective cohort study. The study comprised of 203 patients, aged > or =14 years, admitted with complications of the severe form of leptospirosis at the Emílio Ribas Institute of Infectology (Sao Paulo, Brazil) between 1998 and 2004. Laboratory and demographic data were obtained and the severity of illness score and involvement of the lungs and others organs were determined. Logistic regression was performed to identify independent predictors of LPHS. A prospective validation cohort of 97 subjects with severe form of leptospirosis admitted at the same hospital between 2004 and 2006 was used to independently evaluate the predictive value of the model. RESULTS: The overall mortality rate was 7.9%. Multivariate logistic regression revealed that five factors were independently associated with the development of LPHS: serum potassium (mmol/L) (OR = 2.6; 95% CI = 1.1-5.9); serum creatinine (micromol/L) (OR = 1.2; 95% CI = 1.1-1.4); respiratory rate (breaths/min) (OR = 1.1; 95% CI = 1.1-1.2); presenting shock (OR = 69.9; 95% CI = 20.1-236.4), and Glasgow Coma Scale Score (GCS) < 15 (OR = 7.7; 95% CI = 1.3-23.0). We used these findings to calculate the risk of LPHS by the use of a spreadsheet. In the validation cohort, the equation classified correctly 92% of patients (Kappa statistic = 0.80). CONCLUSIONS: We developed and validated a multivariate model for predicting LPHS. This tool should prove useful in identifying LPHSpatients, allowing earlier management and thereby reducing mortality. 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
Authors: Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz Journal: Lancet Infect Dis Date: 2003-12 Impact factor: 25.071
Authors: H Dupont; D Dupont-Perdrizet; J L Perie; S Zehner-Hansen; B Jarrige; J B Daijardin Journal: Clin Infect Dis Date: 1997-09 Impact factor: 9.079
Authors: P Tattevin; G Léveiller; R Flicoteaux; S Jauréguiberry; Y Le Tulzo; M Dupont; C Arvieux; C Michelet Journal: Lung Date: 2005 Jul-Aug Impact factor: 2.584
Authors: Eddy R Segura; Christian A Ganoza; Kalina Campos; Jessica N Ricaldi; Sonia Torres; Hermann Silva; Manuel J Céspedes; Michael A Matthias; Mark A Swancutt; Renzo López Liñán; Eduardo Gotuzzo; Humberto Guerra; Robert H Gilman; Joseph M Vinetz Journal: Clin Infect Dis Date: 2005-01-10 Impact factor: 9.079
Authors: R T Trevejo; J G Rigau-Pérez; D A Ashford; E M McClure; C Jarquín-González; J J Amador; J O de los Reyes; A Gonzalez; S R Zaki; W J Shieh; R G McLean; R S Nasci; R S Weyant; C A Bolin; S L Bragg; B A Perkins; R A Spiegel Journal: J Infect Dis Date: 1998-11 Impact factor: 5.226
Authors: M Mikulski; P Boisier; F Lacassin; M-E Soupé-Gilbert; C Mauron; L Bruyere-Ostells; D Bonte; Y Barguil; A-C Gourinat; M Matsui; F Vernel-Pauillac; C Goarant Journal: Eur J Clin Microbiol Infect Dis Date: 2014-11-21 Impact factor: 3.267
Authors: Rosane Oliveira; Renan F Domingos; Gabriela H Siqueira; Luis G Fernandes; Natalie M Souza; Monica L Vieira; Zenaide M de Morais; Silvio A Vasconcellos; Ana L T O Nascimento Journal: PLoS Negl Trop Dis Date: 2013-08-29
Authors: Satish P RamachandraRao; Michael A Matthias; Chanthel Kokoy-Mondragon; Chanthel-Kokoy Mondrogon; Eamon Aghania; Cathleen Park; Casey Kong; Michelle Ishaya; Assael Madrigal; Jennifer Horng; Roni Khoshaba; Anousone Bounkhoun; Fabrizio Basilico; Antonella De Palma; Anna Maria Agresta; Linda Awdishu; Robert K Naviaux; Joseph M Vinetz; Pierluigi Mauri Journal: PLoS Negl Trop Dis Date: 2015-03-20
Authors: Tyler M Sharp; Brenda Rivera García; Janice Pérez-Padilla; Renee L Galloway; Marta Guerra; Kyle R Ryff; Dana Haberling; Sharada Ramakrishnan; Sean Shadomy; Dianna Blau; Kay M Tomashek; William A Bower Journal: PLoS Negl Trop Dis Date: 2016-02-25
Authors: Heather S Herman; Saurabh Mehta; Washington B Cárdenas; Anna M Stewart-Ibarra; Julia L Finkelstein Journal: PLoS Negl Trop Dis Date: 2016-07-07